Immunohistochemistry in the diagnosis of malignant mesothelioma
- PMID: 2442887
- DOI: 10.1007/BF00713385
Immunohistochemistry in the diagnosis of malignant mesothelioma
Abstract
The histological diagnosis of malignant mesothelioma of the pleura, especially the distinction from peripheral adenocarcinoma of the lung, may be difficult. The immunohistochemical reports previously published on this subject show diverging results mainly because a variety of antibodies and staining techniques have been used by the different authors. To obtain comparable and reproducible results standard techniques and commercialized antibodies should be applied in routine pathology. In order to investigate the value of immunohistochemistry for the separation of the two entities formalin fixed and paraffin embedded blocks of 47 mesotheliomas and 22 adenocarcinomas were investigated with the PAP technique and commercially available antibodies to carcino-embryonic antigen (CEA), keratin, vimentin, epithelial membrane antigen (EMA), pregnancy specific antigen (SP1), S-100 protein and monoclonal antibody lu-5 (mAB lu-5). CEA positivity was found in all 22 adenocarcinomas examined, but only 2/47 (4%) of all mesotheliomas showed a positive result. SP1 was positive in 13/22 (59%) of the adenocarcinomas, whereas only 3/47 (6%) mesotheliomas were positive for this marker. No significant difference in the rate of positive cases in the adenocarcinoma and mesothelioma group could be found with the other above mentioned antigens. The results of our study indicate that especially CEA, but also SP1 are valuable markers in the diagnosis of malignant mesothelioma.
Similar articles
-
Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.Am J Pathol. 1986 May;123(2):212-9. Am J Pathol. 1986. PMID: 2422942 Free PMC article.
-
The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.Am J Surg Pathol. 1989 Apr;13(4):276-91. Am J Surg Pathol. 1989. PMID: 2648877
-
Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.Acta Cytol. 1987 Nov-Dec;31(6):807-14. Acta Cytol. 1987. PMID: 2447718
-
Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.Am J Clin Pathol. 1998 Jan;109(1):85-9. doi: 10.1093/ajcp/109.1.85. Am J Clin Pathol. 1998. PMID: 9426522 Review.
-
The immunohistochemical diagnosis of epithelial mesothelioma.Hum Pathol. 1999 Mar;30(3):313-23. doi: 10.1016/s0046-8177(99)90011-4. Hum Pathol. 1999. PMID: 10088551 Review.
Cited by
-
[Pleural mesothelioma--problems in diagnosis and clinical course in 25 patients].Langenbecks Arch Chir. 1989;374(2):105-10. doi: 10.1007/BF01261619. Langenbecks Arch Chir. 1989. PMID: 2704280 German.
-
Mesotheliomas of the tunica vaginalis testis and hernial sacs.Virchows Arch A Pathol Anat Histopathol. 1989;415(3):283-92. doi: 10.1007/BF00724916. Virchows Arch A Pathol Anat Histopathol. 1989. PMID: 2503929 Review.
-
Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature.Virchows Arch A Pathol Anat Histopathol. 1990;417(5):443-7. doi: 10.1007/BF01606033. Virchows Arch A Pathol Anat Histopathol. 1990. PMID: 2122588 Review.
-
Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings.Virchows Arch A Pathol Anat Histopathol. 1993;423(1):19-27. doi: 10.1007/BF01606427. Virchows Arch A Pathol Anat Histopathol. 1993. PMID: 8212530
References
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous